Marvel Biosciences Corp. (TSXV:MRVL)
Canada
· Delayed Price · Currency is CAD 0.145
+0.005 (3.57%)
Mar 9, 2026, 9:30 AM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 9.14 million as of March 9, 2026. Its market cap has increased by 31.60% in one year.
Market Cap
9.14M
Enterprise Value
10.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 9.14M, a decrease of -28.09%. That is a compound annual growth rate of -6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.82M | 12.69% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glow Lifetech | 9.08M |
| PharmaTher Holdings | 7.74M |
| Cytophage Technologies | 7.45M |
| Restart Life Sciences | 7.11M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 11.98M |
| COSCIENS Biopharma | 6.40M |
| Kane Biotech | 6.36M |